По вашему запросу найдено документов: 25
Страница 1 из 3
Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in ratHBSP) and infliximab on ischemic renal reperfusion injur. The experiment was performed on 70 white male Wistar
Effect of Anti-TNFα therapy by infliximab against pancreatic tissue damage in severe acute necrotizingn pancreatitisThe present study aimed to study the effect of infliximab on the lethality, volume, and nature
Correction of renal ischemia/reperfusion injury with the Combination of Infliximab and the erythropoietin-derived peptide mimetic pHBSPThe renoprotective activity of the helix B-derived erythropoietin peptide and infliximab has been
Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: Cases series and review of the literature with infliximab and one was treated with adalimumab, respectively. The median duration of treatment was 36 months
INFLIXIMAB IN THE TREATMENT OF IMMUNOGLOBULIN-RESISTANT KAWASAKI DISEASE necrosis factor alpha blocker, infliximab.
СРАВНЕНИЕ ЭФФЕКТИВНОСТИ И БЕЗОПАСНОСТИ БАЗИСНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ И ГЕННО-ИНЖЕНЕРНЫХ БИОЛОГИЧЕСКИХ ПРЕПАРАТОВ ПРИ ПСОРИАТИЧЕСКОМ АРТРИТЕINFLIXIMAB
Modern ideas about juvenile dermatomyositis part 2: Activity assessment and treatment drugs (rituximab, infliximab, adalimumab, golimumab, certolizumab, etanercept), as well as promising new
The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19 – infliximab and adalimumab – are currently being considered as possible options. The safety issues of ITNFα
Страница 1 из 3
Фасеты
Партнеры
Индексация
